Health tech startup H1 lands $58M series B to build out 'LinkedIn for healthcare'

In the middle of a global pandemic, it’s critical for healthcare leaders to be able to connect with other physicians and researchers who are experts in infectious diseases or other areas of medicine impacted by the virus. It turns out startup H1 has the technology to make those connections happen. The startup developed a massive digital professional database and data analytics platform that connects healthcare professionals and life science companies. It basically serves as a LinkedIn for the pharmaceutical and biotech industries. The New York City-based health technology company has experienced explosive growth in 2020 and just raised a $58 million series round of funding, co-led by growth-stage investment firm IVP and Menlo Ventures. Transformation Capital, Lux Capital, Lead Edge Capital, Novartis dRx and YC also participated in the round. Menlo Ventures, a 44-year old venture capital firm, also led the series A round in April 2020. The startup graduated from Y Combinator’s accelerator program back in January and has closed $71 million in funding in 2020. H1’s platform provides comprehensive, in-depth profiles of more than 9 million healthcare professionals and 16,000 institutions in 70-plus countries, all of which are kept up to date weekly. It’s the largest such data…
Read More